En Li, Ph.D.Head, China Novartis Institutes for Biomedical Research
Dr. En Li is Head of Novartis Institutes for BioMedical Research (China) since 2007, where he leads epigenetics research and drug discovery in cancer, liver disease, and regenerative medicine.
He joined Novartis Institutes for BioMedical Research as Vice President and Global Head, Epigenetics Program and Models of Disease in Cambridge, Massachusetts in 2003. Prior to that, he was Associate Professor of Medicine at Harvard Medical School and a member of the Cardiovascular Research Center and Cancer Research Center of Massachusetts General Hospital in Boston.
He received his B.Sc. in biochemistry from Peking University in Beijing and Ph.D. in Biology from MIT in Cambridge, Massachusetts.
BBB-SCBA executive committee